-
1
-
-
0033982172
-
Prevalence of and risk factors for hepatic steatosis in Northern Italy
-
Bellentani S, Saccoccio G, Masutti F, Crocè LS, Brandi G, Sasso F, Cristanini G, Tiribelli C. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med. 2000; 132:112-117
-
(2000)
Ann Intern Med
, vol.132
, pp. 112-117
-
-
Bellentani, S.1
Saccoccio, G.2
Masutti, F.3
Crocè, L.S.4
Brandi, G.5
Sasso, F.6
Cristanini, G.7
Tiribelli, C.8
-
2
-
-
84940645920
-
Nonalcoholic steatohepatitis and insulin resistance in children
-
Arata M, Nakajima J, Nishimata S, Nagata T, Kawashima H. Nonalcoholic steatohepatitis and insulin resistance in children. World J Diabetes. 2014; 5:917-923
-
(2014)
World J Diabetes
, vol.5
, pp. 917-923
-
-
Arata, M.1
Nakajima, J.2
Nishimata, S.3
Nagata, T.4
Kawashima, H.5
-
3
-
-
84880332759
-
The role of leptinemia state as a mediator of inflammation in obese adults
-
Moraes Ados S, Pisani LP, Corgosinho FC, Carvalho LO, Masquio DC, Jamar G, Sanches RB, Oyama LM, Dâmaso AR, Belote C, Caranti DA. The role of leptinemia state as a mediator of inflammation in obese adults. Horm Metab Res. 2013; 45:605-610
-
(2013)
Horm Metab Res
, vol.45
, pp. 605-610
-
-
Moraes Ados, S.1
Pisani, L.P.2
Corgosinho, F.C.3
Carvalho, L.O.4
Masquio, D.C.5
Jamar, G.6
Sanches, R.B.7
Oyama, L.M.8
Dâmaso, A.R.9
Belote, C.10
Caranti, D.A.11
-
4
-
-
84919906960
-
LDL-migration index (LDLMI), an indicator of small dense low-density lipoprotein (sdLDL), is higher in non-alcoholic steatohepatitis than in non-alcoholic fatty liver: a multicenter cross-sectional study
-
Imajo K, Hyogo H, Yoneda M, Honda Y, Kessoku T, Tomeno W, Ogawa Y, Taguri M, Mawatari H, Nozaki Y, Fujita K, Kirikoshi H, Saito S, et al. LDL-migration index (LDLMI), an indicator of small dense low-density lipoprotein (sdLDL), is higher in non-alcoholic steatohepatitis than in non-alcoholic fatty liver: a multicenter cross-sectional study. PLoS One. 2014; 9:e115403
-
(2014)
PLoS One
, vol.9
-
-
Imajo, K.1
Hyogo, H.2
Yoneda, M.3
Honda, Y.4
Kessoku, T.5
Tomeno, W.6
Ogawa, Y.7
Taguri, M.8
Mawatari, H.9
Nozaki, Y.10
Fujita, K.11
Kirikoshi, H.12
Saito, S.13
-
5
-
-
63349085247
-
Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis
-
Paradis V, Zalinski S, Chelbi E, Guedj N, Degos F, Vilgrain V, Bedossa P, Belghiti J. Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis. Hepatology. 2009; 49:851-859
-
(2009)
Hepatology
, vol.49
, pp. 851-859
-
-
Paradis, V.1
Zalinski, S.2
Chelbi, E.3
Guedj, N.4
Degos, F.5
Vilgrain, V.6
Bedossa, P.7
Belghiti, J.8
-
6
-
-
0034116558
-
Liver fibrosis in overweight patients
-
Ratziu V, Giral P, Charlotte F, Bruckert E, Thibault V, Theodorou I, Khalil L, Turpin G, Opolon P, Poynard T. Liver fibrosis in overweight patients. Gastroenterology. 2000; 118:1117-1123
-
(2000)
Gastroenterology
, vol.118
, pp. 1117-1123
-
-
Ratziu, V.1
Giral, P.2
Charlotte, F.3
Bruckert, E.4
Thibault, V.5
Theodorou, I.6
Khalil, L.7
Turpin, G.8
Opolon, P.9
Poynard, T.10
-
7
-
-
33748250671
-
Diagnostic and predictive factors of significant liver fibrosis and minimal lesions in patients with persistent unexplained elevated transaminases A prospective multicenter study
-
de Lédinghen V, Ratziu V, Causse X, Le Bail B, Capron D, Renou C, Pilette C, Oules V, Gelsi E, Oberti F, Vallet-Pichard A, Le-Provost N, Cadranel JF; Association Française pour l'Etude du Foie Groupe Epidémiologie et Evaluation; Association Nationale des Gastroentérologues des Hôpitaux généraux de France. Diagnostic and predictive factors of significant liver fibrosis and minimal lesions in patients with persistent unexplained elevated transaminases. A prospective multicenter study. Hepatology. 2006; 45:592-599
-
(2006)
Hepatology
, vol.45
, pp. 592-599
-
-
de Lédinghen, V.1
Ratziu, V.2
Causse, X.3
Le Bail, B.4
Capron, D.5
Renou, C.6
Pilette, C.7
Oules, V.8
Gelsi, E.9
Oberti, F.10
Vallet-Pichard, A.11
Le-Provost, N.12
Cadranel, J.F.13
-
8
-
-
84922998556
-
Clinical features of hepatocellular carcinoma associated with nonalcoholic fatty liver disease: a review of human studies
-
Oda K, Uto H, Mawatari S, Ido A. Clinical features of hepatocellular carcinoma associated with nonalcoholic fatty liver disease: a review of human studies. Clin J Gastroenterol. 2015; 8:1-9
-
(2015)
Clin J Gastroenterol
, vol.8
, pp. 1-9
-
-
Oda, K.1
Uto, H.2
Mawatari, S.3
Ido, A.4
-
9
-
-
0037838892
-
The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids
-
Briscoe CP, Tadayyon M, Andrews JL, Benson WG, Chambers JK, Eilert MM, Ellis C, Elshourbagy NA, Goetz AS, Minnick DT, Murdock PR, Sauls HR Jr, Shabon U, et al. The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. J Biol Chem. 2003; 28:11303-11311
-
(2003)
J Biol Chem
, vol.28
, pp. 11303-11311
-
-
Briscoe, C.P.1
Tadayyon, M.2
Andrews, J.L.3
Benson, W.G.4
Chambers, J.K.5
Eilert, M.M.6
Ellis, C.7
Elshourbagy, N.A.8
Goetz, A.S.9
Minnick, D.T.10
Murdock, P.R.11
Sauls, H.R.12
Shabon, U.13
-
10
-
-
77952730428
-
The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis
-
Ascha MS, Hanouneh I, Lopez R, Tamimi TA, Feldstein AF, Zein NN. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology. 2010; 51:1972-1978
-
(2010)
Hepatology
, vol.51
, pp. 1972-1978
-
-
Ascha, M.S.1
Hanouneh, I.2
Lopez, R.3
Tamimi, T.A.4
Feldstein, A.F.5
Zein, N.N.6
-
11
-
-
77955625142
-
Population-based risk factors and resource utilization for HCC: US perspective
-
Sanyal A, Poklepovic A, Moyneur E, Barghout V. Population-based risk factors and resource utilization for HCC: US perspective. Curr Med Res Opin. 2010; 26:2183-2191
-
(2010)
Curr Med Res Opin
, vol.26
, pp. 2183-2191
-
-
Sanyal, A.1
Poklepovic, A.2
Moyneur, E.3
Barghout, V.4
-
12
-
-
84859090262
-
Chronic activation of mTOR complex 1 is sufficient to cause hepatocellular carcinoma in mice
-
Menon S, Yecies JL, Zhang HH, Howell JJ, Nicholatos J, Harputlugil E, Bronson RT, Kwiatkowski DJ, Manning BD. Chronic activation of mTOR complex 1 is sufficient to cause hepatocellular carcinoma in mice. Sci Signal. 2012; 5:24
-
(2012)
Sci Signal
, vol.5
, pp. 24
-
-
Menon, S.1
Yecies, J.L.2
Zhang, H.H.3
Howell, J.J.4
Nicholatos, J.5
Harputlugil, E.6
Bronson, R.T.7
Kwiatkowski, D.J.8
Manning, B.D.9
-
13
-
-
80055004124
-
Melanocortin 4 receptor-deficient mice as a novel mouse model of nonalcoholic steatohepatitis
-
Itoh M, Suganami T, Nakagawa N, Tanaka M, Yamamoto Y, Kamei Y, Terai S, Sakaida I, Ogawa Y. Melanocortin 4 receptor-deficient mice as a novel mouse model of nonalcoholic steatohepatitis. Am J Pathol. 2011; 179:2454-2463
-
(2011)
Am J Pathol
, vol.179
, pp. 2454-2463
-
-
Itoh, M.1
Suganami, T.2
Nakagawa, N.3
Tanaka, M.4
Yamamoto, Y.5
Kamei, Y.6
Terai, S.7
Sakaida, I.8
Ogawa, Y.9
-
14
-
-
84879888338
-
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
-
Yoshimoto S, Loo TM, Atarashi K, Kanda H, Sato S, Oyadomari S, Iwakura Y, Oshima K, Morita H, Hattori M, Honda K, Ishikawa Y, Hara E, Ohtani N. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature. 2013; 499:97-101
-
(2013)
Nature
, vol.499
, pp. 97-101
-
-
Yoshimoto, S.1
Loo, T.M.2
Atarashi, K.3
Kanda, H.4
Sato, S.5
Oyadomari, S.6
Iwakura, Y.7
Oshima, K.8
Morita, H.9
Hattori, M.10
Honda, K.11
Ishikawa, Y.12
Hara, E.13
Ohtani, N.14
-
15
-
-
84928473295
-
Metformin suppresses diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-+Leprdb/+Leprdb
-
Ohno T, Shimizu M, Shirakami Y, Baba A, Kochi T, Kubota M, Tsurumi H, Tanaka T, Moriwaki H. Metformin suppresses diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-+Leprdb/+Leprdb. PLoS One. 2015; 10:e0124081
-
(2015)
PLoS One
, vol.10
-
-
Ohno, T.1
Shimizu, M.2
Shirakami, Y.3
Baba, A.4
Kochi, T.5
Kubota, M.6
Tsurumi, H.7
Tanaka, T.8
Moriwaki, H.9
-
16
-
-
85017373900
-
Gut microbiota promotes obesity-associated liver cancer through PGE2-mediated suppression of antitumor immunity
-
Loo TM, Kamachi F, Watanabe Y, Yoshimoto S, Kanda H, Arai Y, Nakajima-Takagi Y, Iwama A, Koga T, Sugimoto Y, Ozawa T, Nakamura M, Kumagai M, et al. Gut microbiota promotes obesity-associated liver cancer through PGE2-mediated suppression of antitumor immunity. Cancer Discov. 2017; 7:522-538
-
(2017)
Cancer Discov
, vol.7
, pp. 522-538
-
-
Loo, T.M.1
Kamachi, F.2
Watanabe, Y.3
Yoshimoto, S.4
Kanda, H.5
Arai, Y.6
Nakajima-Takagi, Y.7
Iwama, A.8
Koga, T.9
Sugimoto, Y.10
Ozawa, T.11
Nakamura, M.12
Kumagai, M.13
-
17
-
-
84955691102
-
DSS colitis promotes tumorigenesis and fibrogenesis in a cholinedeficient high-fat diet-induced NASH mouse model
-
Achiwa K, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Hayashi K, Hirooka Y, Katano Y, Goto H. DSS colitis promotes tumorigenesis and fibrogenesis in a cholinedeficient high-fat diet-induced NASH mouse model. Biochem Biophys Res Commun. 2016; 470:15-21
-
(2016)
Biochem Biophys Res Commun
, vol.470
, pp. 15-21
-
-
Achiwa, K.1
Ishigami, M.2
Ishizu, Y.3
Kuzuya, T.4
Honda, T.5
Hayashi, K.6
Hirooka, Y.7
Katano, Y.8
Goto, H.9
-
18
-
-
84959314003
-
Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice
-
Li J, Sung C, Lee N, Ni Y, Pihlajamäki J, Panagiotou G, El-Nezami H. Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice. Proc Natl Acad Sci USA. 2016; 113:E1306-1315
-
(2016)
Proc Natl Acad Sci USA
, vol.113
, pp. E1306-E1315
-
-
Li, J.1
Sung, C.2
Lee, N.3
Ni, Y.4
Pihlajamäki, J.5
Panagiotou, G.6
El-Nezami, H.7
-
19
-
-
84995776232
-
A novel diet-induced murine model of steatohepatitis with fibrosis for screening and evaluation of drug candidates for nonalcoholic steatohepatitis
-
Ejima C, Kuroda H, Ishizaki S. A novel diet-induced murine model of steatohepatitis with fibrosis for screening and evaluation of drug candidates for nonalcoholic steatohepatitis. Physiol Rep. 2016; 4:e13016
-
(2016)
Physiol Rep
, vol.4
-
-
Ejima, C.1
Kuroda, H.2
Ishizaki, S.3
-
20
-
-
84894875873
-
Free cholesterol accumulation in hepatic stellate cells: mechanism of liver fibrosis aggravation in nonalcoholic steatohepatitis in mice
-
Tomita K, Teratani T, Suzuki T, Shimizu M, Sato H, Narimatsu K, Okada Y, Kurihara C, Irie R, Yokoyama H, Shimamura K, Usui S, Ebinuma H, et al. Free cholesterol accumulation in hepatic stellate cells: mechanism of liver fibrosis aggravation in nonalcoholic steatohepatitis in mice. Hepatology. 2014; 59:154-169
-
(2014)
Hepatology
, vol.59
, pp. 154-169
-
-
Tomita, K.1
Teratani, T.2
Suzuki, T.3
Shimizu, M.4
Sato, H.5
Narimatsu, K.6
Okada, Y.7
Kurihara, C.8
Irie, R.9
Yokoyama, H.10
Shimamura, K.11
Usui, S.12
Ebinuma, H.13
-
21
-
-
84889082596
-
Bile acid-induced inflammatory signaling in mice lacking Foxa2 in the liver leads to activation of mTOR and age-onset obesity
-
Bochkis IM, Shin S, Kaestner KH. Bile acid-induced inflammatory signaling in mice lacking Foxa2 in the liver leads to activation of mTOR and age-onset obesity. Mol Metab. 2013; 2:447-456
-
(2013)
Mol Metab
, vol.2
, pp. 447-456
-
-
Bochkis, I.M.1
Shin, S.2
Kaestner, K.H.3
-
22
-
-
0024847957
-
Purification and characterization of a new hydrolase for conjugated bile acids, chenodeoxycholyltaurine hydrolase, from Bacteroides vulgatus
-
Kawamoto K, Horibe I, Uchida K. Purification and characterization of a new hydrolase for conjugated bile acids, chenodeoxycholyltaurine hydrolase, from Bacteroides vulgatus. J Biochem. 1989; 106:1049-1053
-
(1989)
J Biochem
, vol.106
, pp. 1049-1053
-
-
Kawamoto, K.1
Horibe, I.2
Uchida, K.3
-
23
-
-
84865603263
-
Bile acid binding resin improves metabolic control through the induction of energy expenditure
-
Watanabe M, Morimoto K, Houten SM, Kaneko-Iwasaki N, Sugizaki T, Horai Y, Mataki C, Sato H, Murahashi K, Arita E, Schoonjans K, Suzuki T, Itoh H, Auwerx J. Bile acid binding resin improves metabolic control through the induction of energy expenditure. PLoS One. 2012; 7:e38286
-
(2012)
PLoS One
, vol.7
-
-
Watanabe, M.1
Morimoto, K.2
Houten, S.M.3
Kaneko-Iwasaki, N.4
Sugizaki, T.5
Horai, Y.6
Mataki, C.7
Sato, H.8
Murahashi, K.9
Arita, E.10
Schoonjans, K.11
Suzuki, T.12
Itoh, H.13
Auwerx, J.14
-
24
-
-
59549107896
-
Silibinin inhibits hypoxiainducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy
-
García-Maceira P, Mateo J. Silibinin inhibits hypoxiainducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy. Oncogene. 2009; 28:313-324
-
(2009)
Oncogene
, vol.28
, pp. 313-324
-
-
García-Maceira, P.1
Mateo, J.2
-
25
-
-
84908370960
-
PGE2-induced colon cancer growth is mediated by mTORC1
-
Dufour M, Faes S, Dormond-Meuwly A, Demartines N, Dormond O. PGE2-induced colon cancer growth is mediated by mTORC1. Biochem Biophys Res Commun. 2014; 451:587-591
-
(2014)
Biochem Biophys Res Commun
, vol.451
, pp. 587-591
-
-
Dufour, M.1
Faes, S.2
Dormond-Meuwly, A.3
Demartines, N.4
Dormond, O.5
-
26
-
-
84915750834
-
U12, a UDCA derivative, acts as an anti-hepatoma drug lead and inhibits the mTOR/S6K1 and cyclin/CDK complex pathways
-
Xu Y, Luo Q, Lin T, Zeng Z, Wang G, Zeng D, Ding R, Sun C, Zhang XK, Chen H. U12, a UDCA derivative, acts as an anti-hepatoma drug lead and inhibits the mTOR/S6K1 and cyclin/CDK complex pathways. PLoS One. 2014; 9:e113479
-
(2014)
PLoS One
, vol.9
-
-
Xu, Y.1
Luo, Q.2
Lin, T.3
Zeng, Z.4
Wang, G.5
Zeng, D.6
Ding, R.7
Sun, C.8
Zhang, X.K.9
Chen, H.10
-
27
-
-
84881518400
-
Diacylglycerol kinase ?. couples farnesoid X receptor-dependent bile acid signalling to Akt activation and glucose homoeostasis in hepatocytes
-
Cai K, Sewer MB. Diacylglycerol kinase ? couples farnesoid X receptor-dependent bile acid signalling to Akt activation and glucose homoeostasis in hepatocytes. Biochem J. 2013; 454:267-74
-
(2013)
Biochem J
, vol.454
, pp. 267-274
-
-
Cai, K.1
Sewer, M.B.2
-
28
-
-
74549167737
-
Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression
-
Park EJ, Lee JH, Yu GY, He G, Ali SR, Holzer RG, Osterreicher CH, Takahashi H, Karin M. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell. 2011; 140:197-208
-
(2011)
Cell
, vol.140
, pp. 197-208
-
-
Park, E.J.1
Lee, J.H.2
Yu, G.Y.3
He, G.4
Ali, S.R.5
Holzer, R.G.6
Osterreicher, C.H.7
Takahashi, H.8
Karin, M.9
-
29
-
-
84920401295
-
Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
-
Jiang C, Xie C, Li F, Zhang L, Nichols RG, Krausz KW, Cai J, Qi Y, Fang ZZ, Takahashi S, Tanaka N, Desai D, Amin SG, et al. Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease. J Clin Invest. 2015; 125:386-402
-
(2015)
J Clin Invest
, vol.125
, pp. 386-402
-
-
Jiang, C.1
Xie, C.2
Li, F.3
Zhang, L.4
Nichols, R.G.5
Krausz, K.W.6
Cai, J.7
Qi, Y.8
Fang, Z.Z.9
Takahashi, S.10
Tanaka, N.11
Desai, D.12
Amin, S.G.13
-
30
-
-
84911031215
-
Silencing of microRNA-122 is an early event during hepatocarcinogenesis from nonalcoholic steatohepatitis
-
Takaki Y, Saito Y, Takasugi A, Toshimitsu K, Yamada S, Muramatsu T, Kimura M, Sugiyama K, Suzuki H, Arai E, Ojima H, Kanai Y, Saito H. Silencing of microRNA-122 is an early event during hepatocarcinogenesis from nonalcoholic steatohepatitis. Cancer Sci. 2014; 105:1254-1260
-
(2014)
Cancer Sci
, vol.105
, pp. 1254-1260
-
-
Takaki, Y.1
Saito, Y.2
Takasugi, A.3
Toshimitsu, K.4
Yamada, S.5
Muramatsu, T.6
Kimura, M.7
Sugiyama, K.8
Suzuki, H.9
Arai, E.10
Ojima, H.11
Kanai, Y.12
Saito, H.13
-
31
-
-
84927709697
-
Inhibitors of enhancer of zeste homolog 2 (EZH2) activate tumor-suppressor microRNAs in human cancer cells
-
Hibino S, Saito Y, Muramatsu T, Otani A, Kasai Y, Kimura M, Saito H. Inhibitors of enhancer of zeste homolog 2 (EZH2) activate tumor-suppressor microRNAs in human cancer cells. Oncogenesis. 2014; 3:e104
-
(2014)
Oncogenesis
, vol.3
-
-
Hibino, S.1
Saito, Y.2
Muramatsu, T.3
Otani, A.4
Kasai, Y.5
Kimura, M.6
Saito, H.7
-
32
-
-
36849005392
-
Compromised intestinal lipid absorption in mice with a liver-specific deficiency of liver receptor homolog 1
-
Mataki C, Magnier BC, Houten SM, Annicotte JS, Argmann C, Thomas C, Overmars H, Kulik W, Metzger D, Auwerx J, Schoonjans K. Compromised intestinal lipid absorption in mice with a liver-specific deficiency of liver receptor homolog 1. Mol Cell Biol. 2007; 27:8330-8339
-
(2007)
Mol Cell Biol
, vol.27
, pp. 8330-8339
-
-
Mataki, C.1
Magnier, B.C.2
Houten, S.M.3
Annicotte, J.S.4
Argmann, C.5
Thomas, C.6
Overmars, H.7
Kulik, W.8
Metzger, D.9
Auwerx, J.10
Schoonjans, K.11
-
33
-
-
84987722715
-
microRNA-mediated resistance to hypoglycemia in the HepG2 human hepatoma cell line
-
Ueki S, Murakami Y, Yamada S, Kimura M, Saito Y, Saito H. microRNA-mediated resistance to hypoglycemia in the HepG2 human hepatoma cell line. BMC Cancer. 2016; 16:732
-
(2016)
BMC Cancer
, vol.16
, pp. 732
-
-
Ueki, S.1
Murakami, Y.2
Yamada, S.3
Kimura, M.4
Saito, Y.5
Saito, H.6
|